New Editor-in-Chief per 1 January 2020
We are pleased to announce that Dr. Rong Tian will be appointed as new Editor-in-Chief of the Journal of Molecular and Cellular Cardiology per 1 January 2020. We look forward to collaborating with Dr. Rong Tian in this new position and to welcoming her new editorial team to the journal.
The Journal of Molecular and Cellular Cardiology publishes work advancing knowledge of the mechanisms responsible for both normal and diseased cardiovascular function. To this end papers are published in all relevant areas. These include (but are not limited to): structural biology; genetics; proteomics; morphology; stem cells; molecular biology; metabolism; biophysics; bioengineering; computational modeling and systems analysis; electrophysiology; pharmacology and physiology. Papers are encouraged with both basic and translational approaches. The journal is directed not only to basic scientists but also to clinical cardiologists who wish to follow the rapidly advancing frontiers of basic knowledge of the heart and circulation.
US National Institutes of Health (NIH) voluntary posting ("Public Access") policy
Journal of Molecular and Cellular Cardiology and Elsevier facilitate the author's response to the NIH Public Access Policy. For more details please see the Guide for authors